PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China · Delayed Price · Currency is CNY

32.27

+1.55 (5.06%)

At close: Jul 15, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Discovery	396.98M	316.57M	293.21M	274.73M	234.89M
Drug Discovery Growth	25.40%	7.97%	6.73%	16.96%	77.42%
Process Research and Development	63.71M	48.16M	77.87M	80.31M	92.83M
Process Research and Development Growth	32.28%	-38.15%	-3.04%	-13.49%	187.90%
Commercial Production	197.91M	165.21M	109.40M	117.09M	118.72M
Commercial Production Growth	19.79%	51.02%	-6.57%	-1.37%	4.26%
Unallocated Others	29.76M	14.52M	9.24M	6.76M	1.77M
Unallocated Others Growth	104.86%	57.21%	36.64%	281.02%	-
Total	688.35M	544.47M	489.72M	478.88M	448.21M
Total Growth	26.43%	11.18%	2.26%	6.84%	60.94%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	211.89M	136.62M	147.80M	140.37M	134.43M
China Growth	55.10%	-7.57%	5.30%	4.42%	124.86%
Foreign	476.46M	407.85M	341.92M	338.52M	313.79M
Foreign Growth	16.82%	19.28%	1.00%	7.88%	566.68%
Total	688.35M	544.47M	489.72M	478.88M	448.21M
Total Growth	26.43%	11.18%	2.26%	6.84%	60.94%